Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
Cutanea Life Sciences, Inc. (CLS), an emerging U.S. prescription product development company, formally unveiled its new digital presence, www.cutanea.com, to the dermatology community in conjunction with this winter’s annual gathering of dermatologists from the U.S and around the world. CLS has a stream of innovative product candidates in different stages of development that cover an array of skin conditions, including acne, rosacea, psoriasis and warts caused by human papillomavirus (HPV).
CLS’s new digital presence demonstrates the company’s intent to change the way that customers think about a valued dermatology partner. CLS believes that it can make an impact in the current state of dermatology practice through its commitment to focus on unmet and underserved patient needs. In turn this will help medical professionals optimize their practice time through CLS products and services.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743651-cutanea-life-sciences-dermatology/
The American International Automobile Dealers Association (AIADA) together with the Association of Global Automakers (Global Automakers) today released an economic impact report showcasing the growing impact of the international automakers on the U.S. economy.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7221351-aiada-global-automakers-economic-impact-report-auto-production
Today Match.com announces the MatchMade Scholarship Contest, a $50,000 program open to kids of parents who met on Match. Launched more than 19 years ago, Match has consistently led to more dates, more relationships, and more marriages than any other site. And now, with over one million babies “made” on Match, Match will continue to positively impact the lives of its members by offering a scholarship to the children of its success couples.
To view this Multimedia News Release, go to: http://www.multivu.com/mnr/7209251-match-matchmade-scholarship-contest-children-parents-getaway
The Indexed Annuity Leadership Council (IALC) today unveiled a new initiative that examines the widely varying retirement experience in the United States.
The project, the Changing Face of Retirement in America, is a comprehensive look at modern expectations for retirement and provides regional narratives that show what retirement means for individuals across the country and the economic spectrum, highlighting the impact financial planning can have on retirement.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7484851-ialc-changing-face-of-retirement/
International automakers today are highlighting their investment and dedication to the U.S. auto industry with the launch of Here For America. This new initiative provides a platform for international automakers to share the story of their ever growing impact on the U.S. economy and the benefits they provide to local communities.
“Today’s U.S. auto industry is diverse, vibrant, competitive and global,” said John Bozzella, president and CEO of Global Automakers and spokesman for Here For America. “From the lab to the lot, international automakers are producing high-quality vehicles for consumers here in America and around the globe using local workers and local resources to invigorate local communities.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7223353-global-automakers-here-for-america/
Today, Genesis unveiled its progressive GV80 Concept SUV at the New York International Auto Show. The new fuel cell concept SUV continues to build on the global brand’s expressive and refined ‘Athletic Elegance’ design direction. The GV80 Concept reveals precision details and a confidently evolved design language that provides subtle glimpses into the bold future of Genesis’ design and product development.
The GV80 Concept is the brand’s first interpretation of a versatile luxury SUV, which strikes a perfect balance between elegance and versatility. On the exterior, this is seen in the concept’s confident posture and athletic prowess, while the spacious interior indulges passengers and immerses them in technology that connects them to the vehicle. Recognizing the brand’s global impact, the GV80 Concept utilizes the latest plug-in hydrogen fuel cell electric technology to combine eco-performance and capability, all skillfully designed to fulfill the needs and explore the escapes of the urban adventurer. Genesis will continue to study the benefits of similar alternative propulsion systems and eco-friendly technologies for future product applications.
To view the multimedia release go to:
https://www.multivu.com/players/English/75060512-hyundai-genesis-gv80-guel-cell-concept-suc-nyais/
Today marks the 87th anniversary of the Kingdom of Saudi Arabia. This day provides an opportunity to think about ways to give back to the nation, and there are many ways to give back to one’s country. One of these ways is to preserve the resources that the nation has, and at the forefront of these resources, is energy. It is the vein that Saudi Arabia feeds on to continue its development and prosperity.
For the past three years, the demand for energy increased at a yearly rate of 8%, and is expected to increase up to 58% in the next 25 years. These figures will have an immense impact on oil, especially that 90% of the Kingdom’s revenue is generated from oil exports. While 27% percent of the produced oil is spent on generating energy.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8184051-save-energy-saudi-national-day/
Business and technology goes hand in hand, with the ever changing technology landscape having a significant impact on the way businesses and workers operate. Innovations in the last 10 years have been ground breaking, but there’s even more to come.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63463-wearable-and-wireless-by-2020
Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best.
Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
We Don't Choose Our Parents,Siblings,And Realtives. However, We Choose Our Spouse, We Chose The Person Who Will Have The Most Impact In Our Life. A General Talk By Daee Ahmed Moait. Learn From The Experience Of Others.
Ascensia Diabetes Care today announced the availability of the CONTOUR®NEXT ONE blood glucose monitoring system (BGMS) in the United Kingdom, one of the next steps in the evolution of self-monitoring of blood glucose. As part of the system, the CONTOUR®NEXT ONE meter and CONTOUR®DIABETES app seamlessly connect, which makes capturing blood glucose results effortless for people with diabetes. The system enables patterns and trends to be revealed that can help people understand their diabetes, and may help to improve diabetes management.
The system features an easy-to-use wireless-enabled smart meter that links to a smart mobile device via Bluetooth® connectivity. The CONTOUR®NEXT ONE meter gives immediate feedback and also seamlessly connects to the CONTOUR®DIABETES app, which collects, stores and analyses patient blood glucose results received from the meter. The app combines these results with other data recorded by the user, to provide detailed information about their condition that can help them understand how their everyday lives may impact their blood glucose readings, including alerts for critical high or critical low readings. Through the app, meter users can also share with their healthcare professional the reports of their blood glucose results and patterns, either in advance or on the day of their appointment, helping to create more informed discussions.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7954951-contour-next-one-bgms-ascensia/
